The introduction of enzyme
Enzymes extracted from fungi such as Aspergillus oryzae, Aspergillus Niger and Rhizopus rhizopus have been shown to be safe and effective in treating a variety of clinical conditions. In some cases, fungal enzymes may be more effective than animal-derived enzymes or other treatments available. Some fungal enzyme preparations are particularly suitable for clinical use because of their inherent resistance to gastric acid degradation and their ability to hydrolyze physiologically or pathologically important substrates over a wide pH range.
Clinically, fungal
enzyme preparations are most often taken orally at mealtimes to aid digestion by hydrolyzing dietary substrates such as fats, carbohydrates and proteins. They are also administered intravenously to treat blocked blood vessels, thrombotic diseases and ischemic diseases. Controlled studies in humans and animals have shown the efficacy of various fungal enzyme preparations, both oral and non-oral, in a variety of conditions, including the following:
• Dyspepsia, malabsorption
• The pancreas is not functional
• Gastrointestinal dysfunction
• steatorrhea
• Gluten - related disorders
• Lactose intolerance
• Oligosaccharide-induced gastrointestinal symptoms
• Clogged arteries
• Ischemic disease
• Thrombotic disease
